Tweenvest Stocks

Disc Medicine, Inc. (NasdaqGM: IRON)

Health Care · Biotechnology · US

$79.81

+1.23% today · +32.2% 1Y

Disc Medicine, Inc. (NasdaqGM: IRON) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.06B and employs 165 people.

Over the last twelve months the share price has gained 32.2%, trading between 40.00 and 99.50.

Tweenvest scores Disc Medicine, Inc. across four factors: quality 34/100. Its strongest factor is quality.

IRON price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$3.06B
Revenue (TTM)
P/E
EPS
-6.56
Dividend yield
Beta (5Y)
2.06
52-week high
$99.50
52-week low
$40.00
Avg volume (3M)
Shares outstanding
38.39M
Employees
165
Next earnings

About Disc Medicine, Inc.

Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.

Founded
2017
Listed since
Aug 12, 2020
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$468.22B$264.96+1.20%
Amgen Inc.NasdaqGS: AMGN$237.52B$439.33+1.29%
Gilead Sciences, Inc.NasdaqGS: GILD$181.18B$146.12+1.86%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.91B$548.05+1.44%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.28B$834.04+0.90%
argenx SEENXTBR: ARGX$65.85B902.00+1.90%
Moderna, Inc.NasdaqGS: MRNA$57.92B$145.13+0.04%
CSL LimitedASX: CSL$57.77BAU$168.30-1.69%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.